Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1[BMS-986278][1] BMS-986278 (BMS-986278)[1] Admilparant 💬 [1] LPAR1 💬 [8] Gap junction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Regulation of actin cytoskeleton 💬[1] 85 💬
2BMS-986278[1] BMS-986278 (BMS-986278)[1] Admilparant 💬 [1] LPAR1 💬 [8] Gap junction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Regulation of actin cytoskeleton 💬[1] 85 💬
3BMS-986278Product Code: BMS-986278Pharmaceutical Form: Film-coated tabletINN or Proposed INN: LPA1Current Sponsor code: BMS-986278Other descriptive name: BMS-986278Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 10-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral useProduct Name: BMS-986278Product Code: BMS-986278Pharmaceutical Form: Film-coated tabletINN or Proposed INN: LPA1Current Sponsor code: BMS-986278Other descriptive name: BMS-986278Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 30-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use----[1] 85 💬